News | January 31, 2014

Heart Transplant Success Improving, Patients Living Longer

Many patients live 20 years or more after transplantation

January 31, 2014 — Heart transplant patients may live 20 years or more after surgery, according to a study in The Annals of Thoracic Surgery.
 
Hector Rodriguez Cetina Biefer, M.D. and Markus J. Wilhelm, M.D., from the University Hospital Zurich in Switzerland, led a research team that examined long-term outcomes in 133 patients from their institution who underwent heart transplantation from 1985 to 1991.
 
Among those patients, 74 (55.6 percent) survived at least 20 years post-transplantation. The average age at transplant for the 20-year survivors was 43.6 years.
 
Major causes of death in non-survivors were graft rejection (21 percent), malignancy (21 percent), cardiac allograft vasculopathy (14.5 percent) and infections (14.5 percent).
 
“With continued improvements in immunosuppressive management in the coming years, we expect to see transplant patients living longer, healthier lives,” said Wilhelm. 
 
For more information: www.en.usz.ch

Related Content

Medtronic Announces Global Resolute Onyx DES One-Month DAPT Study
News | Antiplatelet and Anticoagulation Therapies| August 18, 2017
Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual antiplatelet therapy (DAPT...
Bivalirudin exhibited an improvement in 30-day all-cause mortality when injected post PCI.
News | Antiplatelet and Anticoagulation Therapies| August 16, 2017
August 16, 2017 — A study has examined the efficacies of various post-percutaneous coronary intervention (PCI) bivali
CMS considers eliminating cardiac bundled payments.
Feature | Business| August 16, 2017 | Dave Fornell
August 16, 2017 — The Centers for Medicare and Medicaid Services (CMS) announced a proposed rule to reduce the number
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study| August 16, 2017
Aug. 16, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking Clinic
News | Drug-Eluting Balloons| August 15, 2017
Surmodics Inc. announced receipt of an investigational device exemption (IDE) from the U.S. Food and Drug...
The Vascular Dynamics MobiusHD device enhances the carotid baroreceptors to reduce resistant hypertension.
News | Hypertension| August 15, 2017
Aug. 15, 2017 — The U.S. Food and Drug Administration (FDA) has approved the Vascular Dynamics Inc.
Abbott Initiates First Clinical Trial of Clip-Based Tricuspid Repair System
News | Heart Valve Technology| August 09, 2017
Abbott announced that the first patient has been enrolled in a clinical study to evaluate a minimally invasive clip-...
Overlay Init